Concepedia

Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumab

Abraham Boskovitz, Roger E. McLendon, Tatsunori Okamura, John H. Sampson, Darell D. Bigner, Michael R. Zalutsky

Nuclear Medicine and Biology · 2009 · 46 citations · 30 references

DOI

Concepts

References

30

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Andrew Berchuck, Ayman H. Kamel, Regina S. Whitaker et al. · PubMed · 1990 · 765 citations

, , +17

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

Christopher C. Benz, Gary K. Scott, Jay Sarup et al. · Breast Cancer Research and Treatment · 1992 · 760 citations

, , +14

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

Sliwkowski Mx, Lofgren Ja, Lewis Gd et al. · PubMed · 1999 · 654 citations

, , +10

Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Michael F. Press, Carlos Cordon‐Cardo, Dennis J. Slamon · PubMed · 1990 · 648 citations

, , +15

Clinical Experience with α-Particle–Emitting <sup>211</sup>At: Treatment of Recurrent Brain Tumor Patients with <sup>211</sup>At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

Michael R. Zalutsky, David A. Reardon, Gamal Akabani et al. · Journal of Nuclear Medicine · 2007 · 396 citations · Full text

, , +17